Practice Test GeeksPEBC - Pharmacy Examining Board of Canada Practice Test
← All PEBC Flashcard Decks

Treatment Planning Flashcards

7 cards from real PEBC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Treatment Planning flashcards as text

  1. A 30-year-old woman with epilepsy on valproic acid 1000 mg/day is planning a pregnancy. What is the pharmacist's MOST important recommendation?

    Answer: Switch to levetiracetam before conception and start high-dose folic acid 5 mg/day

    Valproic acid carries the highest teratogenic risk among antiepileptics; pre-conception transition to a safer agent plus high-dose folic acid (5 mg/day) is strongly recommended.

  2. A patient with community-acquired pneumonia (CAP) and no comorbidities is treated in an outpatient setting. Per Canadian guidelines, what is the preferred first-line treatment?

    Answer: Doxycycline 100 mg BID for 5–7 days or amoxicillin 1 g TID

    Canadian guidelines recommend amoxicillin or doxycycline as first-line for outpatient CAP in otherwise healthy patients without recent antibiotic use.

  3. A pharmacist identifies that a patient on lithium for bipolar disorder has started ibuprofen regularly for arthritis pain. What is the primary concern?

    Answer: NSAIDs decrease renal clearance of lithium, raising serum levels toward toxicity

    NSAIDs inhibit prostaglandin-mediated renal blood flow, reducing lithium clearance and potentially causing lithium toxicity.

  4. A 72-year-old patient is prescribed temazepam for insomnia. What Beers Criteria concern should the pharmacist raise?

    Answer: Benzodiazepines increase risk of cognitive impairment, falls, and motor vehicle accidents in older adults

    The Beers Criteria lists benzodiazepines as potentially inappropriate in older adults due to increased sensitivity and risks of falls, fractures, and cognitive impairment.

  5. A patient with active tuberculosis is started on standard RIPE therapy. Which combination of adverse effects should the pharmacist monitor for with rifampin?

    Answer: Orange discoloration of body fluids and drug-drug interactions via CYP450 induction

    Rifampin is a potent CYP450 inducer causing numerous drug interactions, and it characteristically turns urine, tears, and sweat orange.

  6. A patient with COPD (FEV1 45% predicted) has increasing exacerbations despite LAMA monotherapy. What is the most evidence-based next step?

    Answer: Add a long-acting beta-2 agonist (LABA) to form LAMA/LABA combination

    GOLD guidelines recommend escalation to LAMA/LABA dual bronchodilation for COPD patients with persistent symptoms or exacerbations on monotherapy before adding ICS.

  7. Which pharmacist action BEST demonstrates collaborative practice in developing a treatment plan for a patient with uncontrolled hypertension?

    Answer: Document a SOAP note with a therapeutic recommendation and communicate it directly to the prescriber

    Documenting a structured pharmacist assessment with a specific therapeutic recommendation and communicating it to the prescriber exemplifies collaborative pharmaceutical care.